During the past decade, Bronson Neurobehavioral Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bronson Neurobehavioral Health" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator and "PharmaConsulting Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Bronson Neurobehavioral Health" are "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Bronson Neurobehavioral Health" in a lesser frequency.

Most popular intervention types in "Bronson Neurobehavioral Health" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AVP-786" (2 trials), "ALZT-OP1a" (1 trials), "ALZT-OP1b" (1 trials), "Placebo" (1 trials) and "Placebo ALZT-OP1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bronson Neurobehavioral Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Bronson Neurobehavioral Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bronson Neurobehavioral Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bronson Neurobehavioral Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".